Log in

NYSE:COOCooper Companies Stock Price, Forecast & News

$285.20
-4.87 (-1.68 %)
(As of 07/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$283.26
Now: $285.20
$293.30
50-Day Range
$270.93
MA: $296.91
$319.22
52-Week Range
$236.68
Now: $285.20
$365.68
Volume750,300 shs
Average Volume358,856 shs
Market Capitalization$15.21 billion
P/E Ratio41.51
Dividend Yield0.02%
Beta0.91
The Cooper Companies, Inc. operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services focusing on women, babies, and families, including medical devices, fertility, genomics, and diagnostics and contraception for hospitals and surgical centers, obstetricians' and gynecologists' (ob/gyns) medical offices, and fertility clinics. In addition, the company offers carrier preimplantation genetic screening, preimplantation genetic diagnosis, and screening used in IVF process; micro pipettes; IVF medical devices and systems; and PARAGARD, a contraceptive option. It markets its products under Biofinity, clarity 1day, MyDay, and Proclear 1 Day brand name through a network of field sales representatives, independent agents, and distributors. The Cooper Companies, Inc. was founded in 1980 and is headquartered in Pleasanton, California.
Read More
Cooper Companies logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 2.7Dividend Strength: 1.7Insider Behavior: 4.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.72 out of 5 stars


Industry, Sector and Symbol

Industry Ophthalmic goods
Sub-IndustryHealth Care Supplies
SectorMedical
CUSIP21664840
Phone925-460-3600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.65 billion
Cash Flow$17.83 per share
Book Value$73.20 per share

Profitability

Net Income$466.70 million

Miscellaneous

Employees12,000
Market Cap$15.21 billion
Next Earnings Date9/3/2020 (Estimated)
OptionableOptionable

Receive COO News and Ratings via Email

Sign-up to receive the latest news and ratings for COO and its competitors with MarketBeat's FREE daily newsletter.

Cooper Companies (NYSE:COO) Frequently Asked Questions

How has Cooper Companies' stock been impacted by COVID-19 (Coronavirus)?

Cooper Companies' stock was trading at $323.89 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, COO shares have decreased by 11.9% and is now trading at $285.20. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Cooper Companies?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cooper Companies in the last year. There are currently 3 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Cooper Companies.

When is Cooper Companies' next earnings date?

Cooper Companies is scheduled to release its next quarterly earnings announcement on Thursday, September 3rd 2020. View our earnings forecast for Cooper Companies.

How were Cooper Companies' earnings last quarter?

Cooper Companies Inc (NYSE:COO) issued its quarterly earnings results on Thursday, June, 4th. The medical device company reported $1.51 EPS for the quarter, missing analysts' consensus estimates of $2.29 by $0.78. The medical device company had revenue of $524.90 million for the quarter, compared to analysts' expectations of $604.78 million. Cooper Companies had a net margin of 13.50% and a return on equity of 14.67%. Cooper Companies's revenue was down 19.7% on a year-over-year basis. During the same period in the previous year, the company earned $2.94 earnings per share. View Cooper Companies' earnings history.

How often does Cooper Companies pay dividends? What is the dividend yield for Cooper Companies?

Cooper Companies announced a semi-annual dividend on Wednesday, January 8th. Stockholders of record on Thursday, January 23rd will be given a dividend of $0.03 per share on Monday, February 10th. The ex-dividend date of this dividend is Wednesday, January 22nd. View Cooper Companies' dividend history.

What price target have analysts set for COO?

11 analysts have issued twelve-month target prices for Cooper Companies' stock. Their forecasts range from $291.00 to $351.00. On average, they anticipate Cooper Companies' stock price to reach $330.73 in the next twelve months. This suggests a possible upside of 16.0% from the stock's current price. View analysts' price targets for Cooper Companies.

Has Cooper Companies been receiving favorable news coverage?

Media headlines about COO stock have been trending negative this week, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Cooper Companies earned a media sentiment score of -2.1 on InfoTrie's scale. They also assigned news articles about the medical device company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news about Cooper Companies.

Who are some of Cooper Companies' key competitors?

What other stocks do shareholders of Cooper Companies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cooper Companies investors own include Netflix (NFLX), NVIDIA (NVDA), Starbucks (SBUX), Adobe (ADBE), Boeing (BA), AbbVie (ABBV), Booking (BKNG), Intuitive Surgical (ISRG), Alibaba Group (BABA) and Walt Disney (DIS).

Who are Cooper Companies' key executives?

Cooper Companies' management team includes the following people:
  • Mr. Albert G. White III, Pres, CEO & Director (Age 49)
  • Mr. Brian G. Andrews, Sr. VP, CFO & Treasurer (Age 40)
  • Mr. Daniel G. McBride, Exec. VP & COO (Age 55)
  • Ms. Holly R. Sheffield, Exec. VP & Chief Strategy Officer (Age 48)
  • Dr. Robert D. Auerbach, Pres of Coopersurgical Inc (Age 58)

What is Cooper Companies' stock symbol?

Cooper Companies trades on the New York Stock Exchange (NYSE) under the ticker symbol "COO."

Who are Cooper Companies' major shareholders?

Cooper Companies' stock is owned by a variety of institutional and retail investors. Top institutional investors include State of Alaska Department of Revenue (0.05%), Watchman Group Inc. (0.01%), Private Trust Co. NA (0.01%), Municipal Employees Retirement System of Michigan (0.01%) and Diversified Trust Co (0.00%). Company insiders that own Cooper Companies stock include A Thomas Bender, Agostino Ricupati, Allan E Rubenstein, Brian G Andrews, Daniel G Mcbride, Gary S Petersmeyer, Holly R Sheffield, Jody S Lindell, Michael Kalkstein, Randal Golden, Robert D Auerbach, Robert S Weiss and Stanley Md Zinberg. View institutional ownership trends for Cooper Companies.

Which institutional investors are selling Cooper Companies stock?

COO stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue. Company insiders that have sold Cooper Companies company stock in the last year include Allan E Rubenstein, Jody S Lindell, and Michael Kalkstein. View insider buying and selling activity for Cooper Companies.

Which institutional investors are buying Cooper Companies stock?

COO stock was bought by a variety of institutional investors in the last quarter, including Watchman Group Inc., Municipal Employees Retirement System of Michigan, Private Trust Co. NA, and Diversified Trust Co. Company insiders that have bought Cooper Companies stock in the last two years include Agostino Ricupati, Allan E Rubenstein, and Holly R Sheffield. View insider buying and selling activity for Cooper Companies.

How do I buy shares of Cooper Companies?

Shares of COO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cooper Companies' stock price today?

One share of COO stock can currently be purchased for approximately $285.20.

How big of a company is Cooper Companies?

Cooper Companies has a market capitalization of $15.21 billion and generates $2.65 billion in revenue each year. The medical device company earns $466.70 million in net income (profit) each year or $12.35 on an earnings per share basis. Cooper Companies employs 12,000 workers across the globe.

What is Cooper Companies' official website?

The official website for Cooper Companies is www.coopercos.com.

How can I contact Cooper Companies?

Cooper Companies' mailing address is 6101 Bollinger Canyon Road Suite 500, San Ramon CA, 94583. The medical device company can be reached via phone at 925-460-3600 or via email at [email protected]

This page was last updated on 7/8/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.